Biopharma | June 05, 2026
Aurobindo Pharma launches TheraNym, India’s largest biologics CMO
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
The robotic cardiac procedure between Guyana and India, established a new benchmark in global telesurgery across nearly 20,000 kilometres
Day-care model aimed at providing specialized psychological support for women during pregnancy and motherhood
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients
Specialised clinic to offer regular device monitoring, battery assessment, rhythm evaluation, and expert cardiac electrophysiology consultation
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
Subscribe To Our Newsletter & Stay Updated
